Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
about
Long-term Monitoring Gait Analysis Using a Wearable Device in Daily Lives of Patients with Parkinson's Disease: The Efficacy of Selegiline Hydrochloride for Gait Disturbance.Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson's Disease.Serotonin, beta-amyloid, and cognition in Parkinson disease.Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study
P2860
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
@ast
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
@en
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
@nl
type
label
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
@ast
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
@en
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
@nl
prefLabel
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
@ast
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
@en
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
@nl
P2093
P2860
P50
P1433
P1476
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.
@en
P2093
Brook Galna
Gordon Duncan
Rosie Morris
Tien K Khoo
P2860
P304
P356
10.1212/WNL.0000000000003840
P407
P577
2017-03-22T00:00:00Z